The Wacky World of Diabetes

David Kliff

The first in a series of podcasts exploring the business side of diabetes

  1. ٢٩‏/٠٩‏/٢٠٢١

    Creating a Global Ecosystem of Meaningful Healthcare with Val Asbury

    At the end of the day what needs to be brought to the marketplace are solutions to problems that consumers face. Val Asbury, CEO of LifeScan, is on a mission to do just that. LifeScan is the maker of One Touch, and Val navigates all its business and operations, which operates around the world with more than 2,000 employees. Her background in nursing and extensive general management experience has been vital in playing a role in the success of her diverse range of leadership, along with an undying passion for ‘meaningful’ healthcare. Let’s get right into the episode and learn from Val how LifeScan is creating a global ecosystem to support meaningful healthcare.  [00:01 - 02:18] Opening Segment I introduce Val AsburyVal shares his background and storyNurse by training A passion for meaningful healthcare Journey into deep diabetes  [02:19 - 14:01] Giving Patients the Ability to Customize Their Wellness Val explains the journey behind the start of competitive bidding What was meant to create choice limited itFrom a fortune 500 to a private equityThe slow processes of a fortune 500 More freedom to move quick under a private equity Keeping the mission front and center Val shares her thoughts on the new world of subscription models The evolution is the most important People are diverse, they should have optionsVal talks about the strategy behind her partnerships The goal is consultingGoing beyond just glucose management CGM coming soonBringing in industry leaders to tailor solutions Soon to launch: consumer portal  [14:02 - 22:58] Creating a Global Ecosystem of Meaningful Healthcare How LifeScan is overcoming the competition A focus on the core business Strategic partnerships with industry leadersA global vision Data from internal systems as well as partners Val talks about the differences in procedures in different countries LifeScan and insulin delivery The move into digital tools A surprising but needed evolution What patients wantAre we solving their problems? [22:59 - 25:32] Closing Segment A change in payer priorities What’s next for Val LifeScan for the long termHow to connect with ValLinks below Final Words  Tweetable Quotes: “If you run a responsible business and you do the right things to support the business, what I’m finding… is we have a lot more latitude and speed to be able to bring solutions into the marketplace.” - Val Asbury “We’ll have so much diversity of the data that we should be able to correlate and talk to people about their health and what combinations work well… and all make a meaningful difference overtime.” - Val Asbury  Connect with Val by checking out https://www.lifescan.com/ and take action to support a life of...

    ٢٦ د

  2. ٠١‏/٠٩‏/٢٠٢١

    A No-Nonsense Perspective on the Business of Insulin with Scott Strumello

    There is a lot happening in insulin sales that are providing benefits; it’s just that most patients aren’t the ones seeing those benefits. Scott Strumello is a consultant, writer, speaker and advocate with those living with T1D. Scott is passionate about getting real information to people by diving into medical data and scientific literature before drawing any conclusions. His ‘no-nonsense’ approach to facts-based reporting has led him to become an authority on all things diabetes investment with a dedicated following on social media.  Jump into the episode and join us for a Scott's perspective on the business of insulin. [00:01 - 02:52] Opening Segment I introduce Scott Strumello Scott shares his background and storyDiagnosed at age 7 Becoming active in the diabetes space The ‘business of diabetes’  [02:53 - 15:59] A No-Nonsense Perspective on the Business of Insulin Scott talks about his current diabetes management Scott’s thoughts on state legislation The effects of Price CapsThe rebate mess A look into the GLP1 space Watching it for trendsScott shares about his audienceAn organic growth process Personal view on insulin Underwhelmed by the G6 [16:00 - 28:01] Reimagining Insulin Legislation  How Scott engages with opposition Scott’s view on apps Why most suck How Scott would do the legislation around insulin Transparency and pass through  [28:02 - 30:35] Closing Segment How to connect with Scott Links below Final Words  Tweetable Quotes: “I find that a lot of apps are developed, particularly by third party developers… I find most of those apps suck… they are solutions in search of a problem to solve.” - Scott Strumello  “I think, first of all, transparency is valuable, but transparency alone isn’t going to ‘fix it’ for patients… Second of all, I think full pass-through of rebates to patients at the point of sale.” - Scott Strumello “I think most insulin is competed on for price, it’s just that most patients don’t get the benefit of it.” - Scott Strumello  Connect with Scott on Twitter. Be sure to check out http://blog.sstrumello.com/ if you want to be up to date with all the latest in Diabetes.  To know more, you can connect with me, David Kliff on Facebook, Twitter, and LinkedIn, or email me at dkliff@diabeticinvestor.com. Be sure to visit a href="https://diabeticinvestor.com" rel="noopener noreferrer"...

    ٣١ د

  3. ١٨‏/٠٨‏/٢٠٢١

    Party Like a Diabetic: Don't Go Through A Diagnosis Alone with Caitlin Grenier

    A diagnosis is not the end, you can still live life to the fullest even with diabetes. Caitlin Grenier is the Founder of Party Like a Diabetic, and is introducing the ultimate health and wellness program that will help you and your patients decrease stress, increase self-esteem, and stabilize blood sugars while living an empowered life. She does this by creating real-world solutions that break the traditional ways of diabetes management that just don’t seem to work. I’m so excited for this episode to give you a ton of value as Caitlin tells us more about her story, Party Like a Diabetic as well as managing, not only diabetes, but the diagnosis itself. [00:01 - 03:09] Opening Segment I introduce Caitlin Grenier Caitlin shares her background and storyHow we met How Caitlin was diagnosed  [03:10 - 10:14] Party Like a Diabetic: Don't Go Through A Diagnosis Alone What is Party Like a DiabeticBook crossed with a journal Links below Caitlin’s management Injections CGM changes the game Why Libre opposed to DexcomReactions to Caitlin’s diagnosisA progression of letting people in  [10:15 - 14:41] Living a Full Life with Diabetes  Why not the pump at first?  Getting comfortable and understanding the bodyThe wireless trend The goal of Party Like a Diabetic You can live a full, empowered lifeLiving without the definition  [14:42 - 16:15] Closing Segment What’s next for Caitlin More books New approaches to diabetes management How to connect with Caitlin and her work Links below Final Words  Tweetable Quotes: “I felt so lost, so frustrated, so confused, and really didn’t know where to turn… I decided I didn’t want anybody to feel like that again… and Party Like a Diabetic came about.” - Caitlin Grenier “You can still live a full, empowered life with diabetes. It doesn’t have to stop you, it doesn’t have to inhibit you.” - Caitlin Grenier  Resources Mentioned:  Sweet Ass JournalDoing It Three Ways: RaceLavaman Connect with Caitlin on Linkedin, Instagram, and Facebook. Check out https://partylikeadiabetic.co/ and grab the journal for yourself. To know more, you can connect with me, David Kliff on a...

    ١٦ د

  4. ٠٤‏/٠٨‏/٢٠٢١

    Bringing Human Connection to Digital Health with David G. Weingard

    With the rise in digital diabetes health, with all it’s benefits, many feel we are still missing out on the human element. David Weingard is changing that. David is the Founder of Cecelia Health (formerly Fit4D), whose mission is to improve the lives of people living with diabetes and other chronic diseases throughout the world. The company is dedicated in honor and memory of Cecelia Bourne-Cort, who helped David rebuild his life after his diagnosis with Type 1 diabetes.  Dive in and learn how David is creating a platform with paying clients looking to succeed in bringing human connection to digital health.  [00:01 - 05:38] Opening Segment I introduce David G. WeingardDavid shares his background and storyDavid’s diabetes journey The story behind of Cecelia Health David’s management and regiment after getting diagnosedInsulin pumps at firstThe tracking processDavid’s CGM experience [04:39 - 13:12] Bringing Human Connection to Digital Health  David talks about his work with Cecelia Two groups of clients The way Cecelia helps people personally How Cecelia is human driven The usability The use of expert clinicians Improving outcomes through engagement How they manage engagement Segmentation of the populationFinding out what they need Key partnerships Benefits of the Lifescan partnership [13:13 - 17:52] What Investors Need to Understand Investor misconceptions about the digital space People think the app is the solution Understanding of the magnitude The need for telemedicine What’s next for CeceliaThe virtual flavorDiabetes health care and mental health The ability for medication adjustments How they plan to grow Current stance and expectations [17:53 - 29:02] Closing Segment The impact of at-risk-contractingHow Cecelia’s health plans work Positive demonstrations and metricsSensitive to app fatigue Final Words  Tweetable Quotes: “What we do that’s different… We leverage an expert diabetes clinician, clinicians who really understand their devices, who really understand diabetes and of course their nurses, dietitians, or pharmacists; and they proactively reach out to patients.” - David G. Weingard “For us it’s all about growth now… It’s all about - how much can we scale to help people as fast as we can?” - David G. Weingard Resources Mentioned:  Lifescan Connect with David on LinkedIn. Check out https://www.ceceliahealth.com/ to learn more about a flexible approach to a chronic condition.   To know more, you can connect...

    ٢٠ د

  5. ١٥‏/٠٧‏/٢٠٢١

    Afrezza: The Future of Insulin Innovation with MannKind CEO Michael Castagna

    It’s time to give patients a chance to do something different to gain control of their disease. Michael Castagna is the CEO of MannKind, the company on the - “cutting edge of helping transform the care of diabetes where people can really get real-time control.” Michael is an entrepreneurial executive with more than 20 years of experience in the strategic development in Fortune 500 companies as well as privately held biotech start-ups. His innovation is driven by a mission to develop the products and therapies that can help people take control of their health and experience the best of what life has to offer. Let’s dive right into this episode where you’ll learn how Afrezza hit the market, how it’s changing the speed of the ‘in and out’ of insulin, how it all works, and how it may just be the future of insulin. [00:01 - 05:36] Opening Segment I introduce Michael CastagnaMichael shares his background and storyJourney and success in the pharmaceutical world The approval of Afrezza  [05:37 - 13:53] The Fastest Acting Insulin on the Market Michael shares the touch and go process of Afrezza Mistake made along the wayInvesting his own money Getting back on trackExplaining the inner workings of Afrezza Human insulin Fast acting How it gets out of the bodyFollowing the pediatrics Green light to phase 3 [13:54 - 25:16] Impacting Mankind with MannKind Partnerships with doctorsThe ones who understand take it on board Michael talks about the transition process of MannKindRoyalties Pipeline Technology Current numbersMichael looks out to the next 5 years of MannKind and AfrezzaThoughts on acquisitions Organic growth and shareholder value Afrezza as a global product Launching the next drugs [25:17 - 29:02] Closing Segment The future of InsulinMichaels final message to listeners You have nothing to lose Try a new tool and get to know itThink about your patients Final Words  Tweetable Quotes: “I liked running into the fires and fixing things…” - Michael Castagna “It works fast, it works completely different from injectable insulin… It’s in and out of the body quickly.” - Michael Castagna “Why not try a whole new tool…? We’re going to be here for the next 20 years. Your patients want to try this. Give them a chance to do something different to gain control of their disease.” - Michael Castagna Resources Mentioned:  Afrezza Connect with Michael on Twitter, LinkedIn, and a...

    ٢٩ د

  6. ٠١‏/٠٧‏/٢٠٢١

    Blogs, Forums, and Social Media Leading Patient Advocacy with Amy Tenderich

    The internet is bringing people together like never before. Amy Tenderich is a journalist, blogger, and nationally known patient advocate. She hosts a series of diabetes innovation leadership events, and is a frequent public speaker on diabetes and digital health topics and is also the Co-author of the book, "Know Your Numbers, Outlive Your Diabetes." Since Amy launched DiabetesMine.com, it’s become one of the Top Health Blogs in the country and worldwide and has joined Healthline Media to create summits and forums to help bring people together. Don’t miss out on this conversation, jump in and learn more about how Amy’s work has led to patient advocacy. [00:01 - 06:41] Opening Segment I introduce Amy TenderichAmy shares her background and storyBecoming an advocate for patients as a patient The growth of DiabetesMineInnovating diabetes tech early onLaunching events and forums to bring people together [06:42 - 16:31] The Growing Interactions Between Diabetes and Social Media Amy talks about the changes from then vs. nowFrom exciting peer support to something taken for grantedA growing sense of anger and feeling of exploitationThe social media activity between T1D and T2DA growing voice Findings from research How to deal with misinformation and abuse Moderations Two-way communication The problems of comparisonHow Amy navigates consumer and client requests  [16:32 - 23:44]  Amy’s views on ‘digital diabetes’The evolution of our worldTop things consumers say change their lifeCGM is the number one thingA mix of online resources and community Looping systems and online appointments How different demographics respond to diagnosis Are vendors getting it? What people want vs. practicality  [23:45 - 31:07] Closing Segment What’s next for Amy and DiabetesMine?Using strengths to advocate for the community Future events and forums Helping people feel represented Organizations attempting to respond to criticism Projecting 7 years into the future Final Words  Tweetable Quotes: “A lot of people who thought that they would not like to have online doctors appointments have actually found that it’s really convenient and they often get just as good attention from their doctors, sometimes maybe even better.” - Amy Tenderich “People want to do the least possible for their diabetes and get the best possible outcomes.” - Amy Tenderich  Resources Mentioned:  Know Your Numbers, Outlive Your Diabetes Connect with Amy on Twitter, LinkedIn, and a href="https://www.facebook.com/amy.tenderich" rel="noopener noreferrer"...

    ٣١ د

  7. ٢٣‏/٠٦‏/٢٠٢١

    Complex Algorithm, Simple User Experience with Diabeloop

    Today I have the pleasure of sitting down with the Diabeloop crew. Diabeloop has been involving people living with Type 1 diabetes and their families and has contributed to the development alongside engineers and healthcare professionals. The focus is on ease of use and intuitive interfaces that are inspired by users themselves.  I can’t wait to get started and learn how they are revolutionizing the future of diabetes through their complex algorithm that provides a simple user experience. [00:01 - 04:25] Opening Segment I introduce the Diabloop crewEric shares his background How Diabeloop worksComparing and contrastingInteraction and tuningGiving users choice [04:26 - 13:04]  Unique Algorithm and Strategic Partnerships Eric explains the algorithm Taking into account lifestyle and physiology as a wholeStrategic deals Diabeloop has madeThe Roche dealHelping the transition to get something in people’s handsComplementary deal with Roche and BiocorpEric’s thoughts on the commoditization of closed loop algorithmsThe algorithm should work with what we have [13:05 - 25:20] Complicated Algorithm, Simple User Experience  The importance of a simple user experienceDifferent algorithms developing - 5 year projection Algorithms will advanceHow Diabeloop makes moneySelling a monthly subscription for the algorithm ReimbursementHow to bring this to USMust have FDA approvalDistribution partnershipsFrom Diabeloop to doctor to patientWhy you should go with DiabeloopThe algorithm gets smarter as you where itZen mode [25:21 - 29:48] Closing Segment How Diabeloop is going to change the futureThe power of choiceBecoming less intensively managed Testimonial Shacey’s projections on insulinExciting things in the pipelineThe dynamics of running a public companyPlay to win not to surviveTechnology is outpacing the health machine complexWe’re all in this togetherThe introduction of utilizing people’s informationFinal Words  Tweetable Quotes: “Some people want to be able to have as fine tuned control as possible… You can't separate physiology and lifestyle.” - Eric Honaker, Diabeloop Connect with Diabeloop on Twitter. Go check out https://www.diabeloop.com/  To know more, you can connect with me, David Kliff on Facebook, Twitter, and a href="https://www.linkedin.com/in/david-kliff-78b669b/" rel="noopener noreferrer"...

    ٢٨ د

  8. ١٦‏/٠٦‏/٢٠٢١

    Bringing Innovation to the Market with Tubeless Omnipod Technology with Shacey Petrovic

    There is new, winning technology coming to the market that is easier to use than a smartphone, adaptive, completely wireless, and fully controllable by users. Shacey Petrovic is the CEO of Insulet, an innovative medical device company making the lives of people with diabetes easier through the use of its Omnipod product platform. Shacey has a strong background in med tech and life sciences, but also takes the diabetes market by storm with her skills in commercial leadership, sales, marketing, and 'put the patient first' mentality. An incredible individual, I can’t wait for us to dive in and learn from Shacey how she is bringing innovation to the market with tubeless Omnipod technology. [00:01 - 03:15] Opening Segment I introduce Shacey Shacey’s background and experienceMed tech and business background Working in women’s health Recruited to Insulet Synergies between diabetes and women’s health careThe challenges and rewardsThe shock of industry dynamics drive rather than patient welfare [03:16 - 15:20]  Bringing Innovation to the Market with Tubeless Omnipod Technology Differences from the conventional insulin pump modelGetting better outcomes for patientsWhy so many are converting to MDIBetter control Reducing burden Great to be wireless/tubeless Shacey talks about the Omnipod 5 and its features What makes it transformative The first tubeless insulin deliveryControlled via smartphone Adaptive features FDA supportForward leaning with diabetes innovation Shacey’s thoughts on prefilled cartridge delivery  [15:21 - 23:58] How Omnipod 5 Navigates the Digital Market Shacey talks about Insulet and the Insulin industryGetting people broader access Reducing burden for users Thoughts on entering the Amazon marketplaceThe benefit of working with co-pays over deductibles Predictable and affordable Shacey shares about the drug delivery systemStrategic partnerships A wave of innovation in the marketNavigating the new challenges in the marketTelehealth and virtual training Balancing in-person with at-homeHow Omnipod 5 takes on the new challenges [23:59 - 29:48] Closing Segment Let’s talk five to seven years out The launch of Omnipod 5CGM data in the worksOnly simple and effective solutionsShacey’s projections on insulinExciting things in the pipelineThe dynamics of running a public companyPlay to win not to surviveTechnology is outpacing the health machine complexWe’re all in this togetherThe introduction of utilizing people’s informationFinal Words  Tweetable Quotes: “All of our users and what my team is excited about is that this will really leapfrog the...

    ٣٠ د
مشاهدة الكل (١٩)

حول

The first in a series of podcasts exploring the business side of diabetes

المعلومات

  • صناع العمل
    David Kliff
  • سنوات النشاط
    ٢٠٢٠ - ٢٠٢١
  • الحلقات
    ١٩
  • التقييم
    ملائم
  • حقوق النشر
    © Copyright 2023 David Kliff
  • موقع البرنامج على الويب
    The Wacky World of Diabetes